Clinical Laserthermia Systems AB (CLS) develops and markets the TRANBERG®|Thermal Therapy System, as well as disposable materials and methods, for heat-induced immunotherapy enabling safe and gentle treatment of cancerous tumors.
The products are marketed for image guided laser ablation and for CLS’ own immunostimulating therapy, imILT®.
The Company is headquartered in Lund, Sweden, with subsidiaries in Berlin, Germany and in Boston, USA.
CLS is listed on Nasdaq First North under the stock symbol CLS B.
Company’s Keywords:
<15
<
<2017
Your request has been submitted successfully.
Own or work here?